Krishna Institute of Medical Sciences Q4 FY26 results (Jan–Mar 2026) and concall

Healthcare · Concall AI · Call held 18 May 2026

Company page: Krishna Institute of Medical Sciences share price, financials & guidance record

KIMS Hospitals reported robust revenue growth in Q4 and FY26, driven by new unit expansions. However, initial operational drag from these new facilities led to significant EBITDA margin compression and a sharp decline in PAT and EPS. Management highlighted challenges with insurance empanelment for new hospitals but expressed confidence in ramp-up and profitability improvement, supported by a planned QIP to reduce debt and fund future greenfield projects.

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q4 FY26: revenue up 31.8%, net profit down 29.8% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26
Revenue	363	348	346	373	430 +18%	442 +27%	456 +32%
Expenses	252	245	237	276	318	314	326
EBITDA	111	103	109	98	112 +1%	128 +24%	130 +19%
Margin	31%	30%	31%	26%	26%	29%	29%
Other income	7	21	35	12	12	14	11
Interest	5	7	8	12	18	22	27
Depreciation	14	15	15	18	20	23	26
Profit before tax	99	102	120	80	86 −13%	98 −4%	89 −26%
Tax rate	27%	25%	22%	26%	26%	26%	26%
Net profit	72	76	94	59	64 −11%	72 −5%	66 −30%
EPS	1.80	1.91	2.34	1.47	1.59	1.81	1.65

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls